HBsAg-话题@MedSci

#HBsAg#

29篇内容 | 1186人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200404, encodeId=9cba2200404a8, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=5fcb113801f8' target=_blank style='color:#2F92EE;'>#HBsAb#</a>, objectTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, objectType=article, longId=822489, objectId=19b2822489a0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=19b2822489a0, replyNumber=0, likeNumber=2, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=19b2822489a0, moduleTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19b2822489a0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198415, encodeId=6d132198415a6, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=a3f3e07054' target=_blank style='color:#2F92EE;'>#ETV#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, objectType=article, longId=819902, objectId=03ec819902f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=03ec819902f2, replyNumber=0, likeNumber=10, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=03ec819902f2, moduleTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03ec819902f2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195713, encodeId=ff4b2195e1313, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, objectType=article, longId=818046, objectId=1507818046bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=1507818046bd, replyNumber=0, likeNumber=15, createdTime=2024-03-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=1507818046bd, moduleTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1507818046bd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195033, encodeId=6e572195033d1, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a>, objectTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, objectType=article, longId=817866, objectId=711d81e866ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medic-563425_640.jpg, objectUrl=/article/show_article.do?id=711d81e866ea, replyNumber=0, likeNumber=9, createdTime=2024-03-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=711d81e866ea, moduleTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711d81e866ea)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194743, encodeId=8d0c2194e438c, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, objectType=article, longId=817491, objectId=fe6681e491f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=fe6681e491f3, replyNumber=0, likeNumber=18, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe6681e491f3, moduleTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6681e491f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191161, encodeId=a2e3219116104, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%, objectType=article, longId=815457, objectId=e98581545e40, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/ccd0b61f0a3894a4bf51f2d065f58b9849794aa5.jpg, objectUrl=/article/show_article.do?id=e98581545e40, replyNumber=0, likeNumber=19, createdTime=2024-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e98581545e40, moduleTitle=【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e98581545e40)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190737, encodeId=cb792190e37a0, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a>, objectTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, objectType=article, longId=815453, objectId=e5e181545363, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=e5e181545363, replyNumber=0, likeNumber=21, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5e181545363, moduleTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e181545363)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182292, encodeId=501021822920c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=1315194e2b7' target=_blank style='color:#2F92EE;'>#丁型肝炎病毒#</a> <a href='/topic/show?id=4ba78623f2' target=_blank style='color:#2F92EE;'>#HDV#</a>, objectTitle=学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点, objectType=article, longId=809127, objectId=bcf680912e20, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=bcf680912e20, replyNumber=0, likeNumber=25, createdTime=2024-01-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bcf680912e20, moduleTitle=学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcf680912e20)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1338679, encodeId=cf5a13386e9ab, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, objectType=article, longId=736354, objectId=8d4ce36354d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4ce36354d3, replyNumber=0, likeNumber=43, createdTime=2022-08-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4ce36354d3, moduleTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4ce36354d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338678, encodeId=3e6113386e86a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关, objectType=article, longId=724928, objectId=8a71e249284f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a71e249284f, replyNumber=0, likeNumber=35, createdTime=2022-04-26, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a71e249284f, moduleTitle=Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a71e249284f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338677, encodeId=542813386e740, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, objectType=article, longId=206053, objectId=87a720605372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87a720605372, replyNumber=0, likeNumber=53, createdTime=2021-01-24, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87a720605372, moduleTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87a720605372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338676, encodeId=7ce813386e63a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【华西检验案例】HBsAg转阴＝HBV根除？, objectType=article, longId=198277, objectId=1f231982e78c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f231982e78c, replyNumber=0, likeNumber=45, createdTime=2020-07-30, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f231982e78c, moduleTitle=【华西检验案例】HBsAg转阴＝HBV根除？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f231982e78c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338675, encodeId=2f4f13386e5bf, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？, objectType=article, longId=190371, objectId=f6061903e196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6061903e196, replyNumber=0, likeNumber=44, createdTime=2020-03-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6061903e196, moduleTitle=Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6061903e196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338674, encodeId=43c813386e4b3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少, objectType=article, longId=181629, objectId=5c1818162931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1818162931, replyNumber=0, likeNumber=33, createdTime=2019-10-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1818162931, moduleTitle=J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1818162931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338673, encodeId=f0dc13386e3c3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率..., objectType=article, longId=161282, objectId=7ecf1612824c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ecf1612824c, replyNumber=0, likeNumber=29, createdTime=2019-02-28, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ecf1612824c, moduleTitle=Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率..., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ecf1612824c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338672, encodeId=061e13386e27c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志, objectType=article, longId=159331, objectId=593f15933160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=593f15933160, replyNumber=0, likeNumber=34, createdTime=2019-02-02, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=593f15933160, moduleTitle=Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=593f15933160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338671, encodeId=c0a013386e1c4, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=J Hepatol：应用NAs实现病毒学完全抑制后HBsAg清除能够进一步降低肝癌的发生风险, objectType=article, longId=157047, objectId=7dc215e04774, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dc215e04774, replyNumber=0, likeNumber=51, createdTime=2018-12-31, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dc215e04774, moduleTitle=J Hepatol：应用NAs实现病毒学完全抑制后HBsAg清除能够进一步降低肝癌的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dc215e04774)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338670, encodeId=684b13386e020, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【获奖案例】HBsAg阴性，HBV-DNA阳性, objectType=article, longId=142878, objectId=30201428e862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30201428e862, replyNumber=0, likeNumber=54, createdTime=2018-07-11, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30201428e862, moduleTitle=【获奖案例】HBsAg阴性，HBV-DNA阳性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30201428e862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338669, encodeId=e8ae133866901, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=JCLA：高灵敏度化学发光酶免疫测定HBsAg HQ对乙肝病毒筛查, objectType=article, longId=139668, objectId=3be5139668ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be5139668ae, replyNumber=0, likeNumber=44, createdTime=2018-06-02, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be5139668ae, moduleTitle=JCLA：高灵敏度化学发光酶免疫测定HBsAg HQ对乙肝病毒筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be5139668ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338668, encodeId=478a13386683e, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, objectType=article, longId=135062, objectId=0b8e13506250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b8e13506250, replyNumber=0, likeNumber=29, createdTime=2018-04-13, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b8e13506250, moduleTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b8e13506250)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #HBsAb#

【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈

2024-04-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #ETV# #慢乙肝#

【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除

2024-04-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #HBV# #HBsAg#

【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素

2024-03-27发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗#

【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平

2024-03-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #HBsAg# #HBV#

【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈

2024-03-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗# #HBV#

【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%

2024-03-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #核苷#

【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群

2024-03-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #丁型肝炎病毒# #HDV#

学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点

2024-01-17发表于陕西省

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关

2022-08-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关

2022-04-26

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况

2021-01-24

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

【华西检验案例】HBsAg转阴＝HBV根除？

2020-07-30

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？

2020-03-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少

2019-10-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率...

2019-02-28

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志

2019-02-02

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

J Hepatol：应用NAs实现病毒学完全抑制后HBsAg清除能够进一步降低肝癌的发生风险

2018-12-31

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

【获奖案例】HBsAg阴性，HBV-DNA阳性

2018-07-11

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

JCLA：高灵敏度化学发光酶免疫测定HBsAg HQ对乙肝病毒筛查

2018-06-02

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略

2018-04-13

科室
- - 订阅+
  - 更多科室
工具
服务